RESUMEN
Abstract Chronic kidney disease (CKD) has severe consequences on the quality and expectancy of life and is considered a major health problem worldwide. This is, especially relevant in pediatric patients, as they have unique characteristics and a mortality rate 30 times higher (in advanced stages) than healthy people. This review aims to define the minimum components for the diagnostic approach and monitoring of CKD in the pediatric population from primary health care to promote comprehensive care and adequate risk management. For this purpose, we performed a systematic review of the literature with a panel of experts. Based on the evidence, to optimize the definition, diagnosis, and timely treatment of CKD in the pediatric population, we formulated 21 recommendations. These were approved by the research team and peer-reviewed by clinical experts. They will facilitate the definition of the diagnostic approach for CKD in the pediatric population in primary health-care settings, allowing for timely treatment intervention, comprehensive care, and monitoring of this disease.
Resumen La enfermedad renal crónica (ERC) tiene graves consecuencias en la calidad y la esperanza de vida, y se considera un importante problema de salud a nivel mundial. Esto es especialmente relevante en pacientes pediátricos, ya que presenta características únicas y una tasa de mortalidad en etapas avanzadas que es 30 veces mayor que en personas sanas. El objetivo de esta revisión fue definir los componentes mínimos para el abordaje diagnóstico y para el seguimiento de la ERC en la población pediátrica desde la atención primaria en salud, con el fin de promover la atención integral y una adecuada gestión del riesgo. Para esto, se realizó una revisión sistemática de la literatura con panel de discusión de expertos. Basándonos en la evidencia, y con el objetivo de optimizar la definición, diagnóstico y tratamiento oportuno de la ERC en la población pediátrica, se formularon 21 recomendaciones. Estas fueron aprobadas por el equipo desarrollador y los pares expertos clínicos evaluadores, y permitirán definir de manera oportuna el abordaje diagnóstico de la ERC en la población pediátrica desde la atención primaria en salud, facilitando la intervención temprana, una atención integral y el seguimiento de esta patología.
RESUMEN
Chronic kidney disease (CKD) has severe consequences on the quality and expectancy of life and is considered a major health problem worldwide. This is, especially relevant in pediatric patients, as they have unique characteristics and a mortality rate 30 times higher (in advanced stages) than healthy people. This review aims to define the minimum components for the diagnostic approach and monitoring of CKD in the pediatric population from primary health care to promote comprehensive care and adequate risk management. For this purpose, we performed a systematic review of the literature with a panel of experts. Based on the evidence, to optimize the definition, diagnosis, and timely treatment of CKD in the pediatric population, we formulated 21 recommendations. These were approved by the research team and peer-reviewed by clinical experts. They will facilitate the definition of the diagnostic approach for CKD in the pediatric population in primary health-care settings, allowing for timely treatment intervention, comprehensive care, and monitoring of this disease.
La enfermedad renal crónica (ERC) tiene graves consecuencias en la calidad y la esperanza de vida, y se considera un importante problema de salud a nivel mundial. Esto es especialmente relevante en pacientes pediátricos, ya que presenta características únicas y una tasa de mortalidad en etapas avanzadas que es 30 veces mayor que en personas sanas. El objetivo de esta revisión fue definir los componentes mínimos para el abordaje diagnóstico y para el seguimiento de la ERC en la población pediátrica desde la atención primaria en salud, con el fin de promover la atención integral y una adecuada gestión del riesgo. Para esto, se realizó una revisión sistemática de la literatura con panel de discusión de expertos. Basándonos en la evidencia, y con el objetivo de optimizar la definición, diagnóstico y tratamiento oportuno de la ERC en la población pediátrica, se formularon 21 recomendaciones. Estas fueron aprobadas por el equipo desarrollador y los pares expertos clínicos evaluadores, y permitirán definir de manera oportuna el abordaje diagnóstico de la ERC en la población pediátrica desde la atención primaria en salud, facilitando la intervención temprana, una atención integral y el seguimiento de esta patología.
Asunto(s)
Atención Primaria de Salud , Insuficiencia Renal Crónica , Humanos , Insuficiencia Renal Crónica/diagnóstico , Insuficiencia Renal Crónica/terapia , Niño , Atención Integral de Salud/organización & administraciónRESUMEN
Introducción. La enfermedad renal crónica es responsable de aproximadamente 2,4 millones de defunciones a nivel mundial. La supervivencia a los cinco años después de iniciar diálisis se encuentra entre un 39 a 60 % dependiendo del país. Objetivo. Describir la situación epidemiológica de los pacientes con diálisis y analizar los factores que influyen en la supervivencia de pacientes a cinco años de iniciar tratamiento sustitutivo renal en El Salvador. Metodología. Estudio de cohorte retrospectivo de los pacientes incluidos en el Registro Nacional de Diálisis y Trasplante Renal desde enero de 2016 hasta febrero de 2023. El seguimiento se comenzó al inicio de la diálisis, el evento de interés fue la muerte del paciente. Se utilizó el método de Kaplan-Meier para determinar la supervivencia al año y a los cinco años y la regresión de Cox con el modelo de Royston-Parmar para analizar los factores que influyen sobre la supervivencia a los cinco años. Resultados. El estudio incluyó 7088 pacientes, la supervivencia a uno y cinco años fue del 79,5 % (IC 95 %: 78,6-80,5) y 50,6 % (IC 95 %: 49,1-52,1) respectivamente. La regresión de Cox para la edad de inicio de tratamiento resultó en un hazard ratio de 1,02 (IC 95 %: 1,01-1,02), mientras que para el oficio de ser agricultor el hazard ratio fue 1,1 (IC 95 %: 1,01-1,18) y para la etiología hipertensiva el hazard ratio fue de 0,7 (IC 95 %: 0,64-0,78). Conclusión. La edad de inicio de tratamiento y el ser agricultor están asociados con una menor supervivencia a cinco años en pacientes con diálisis
Introduction. The chronic kidney disease is responsible for approximately 2.4 million deaths worldwide, in El Salvador during 2019 death rate was 72.9 for 100 000 habitants, five year survival in patients after starting dialysis was between 39 and 60 % depending on the country. Objective. Analyze the factors that influence the five years survival in patients after starting renal replacement therapy in El Salvador. Methodology. It is a retrospective cohort study from patients included in dialysis and renal replacement therapy national registry from January 2016 to February 2023, the start point for the following was the initiation of dialysis, the event of interest was patient Ìs death, the Kaplan-Meier method was used to determine one year and five year survival; and Cox regression with Royston-Parmar model was used to analyze the factors that influence survival. Results. The study included 7088 patients, one and five-years survival was 79.5 % (CI 95 %: 78.6-80.5) and 50.6 % (CI 95 %: 49.1-52.1) respectively. The Cox regression for age of treatment initiation resulted in a hazard ratio of 1.02 (CI 95 %: 1.01-1.02), while for farmers, the hazard ratio was 1.09 (CI 95 %: 1.00-1.18), for hypertensive etiology the hazard ratio was 0.7 (CI 95 %: 0.64-0.78). Conclusion. Data suggest that age of treatment initiation, and jobs related to agriculture were associated with less five year survival in dialysis patients.
Asunto(s)
Insuficiencia Renal , El SalvadorRESUMEN
ABSTRACT BACKGROUND: The prevalence of chronic kidney disease (CKD) has increased in the recent decades, along with the number of patients in the terminal stages of this disease, requiring transplantation. Some skin disorders are more frequent in patients with CKD and in renal transplant recipients (RTR). OBJECTIVES: To evaluate the frequency of skin diseases in RTR and patients with CKD receiving conservative treatment. DESIGN AND SETTING: This observational cross-sectional study recruited consecutive patients with CKD and RTR from a nephrology clinic at a teaching hospital in Brazil between 2015 and 2020. METHODS: Quantitative, descriptive, and analytical approaches were used. The sample was selected based on convenience sampling. Data were collected from dermatological visits and participants' medical records. RESULTS: Overall, 308 participants were included: 206 RTR (66.9%, median age: 48 years, interquartile range [IQR] 38.0-56.0, 63.6% men) and 102 patients with CKD (33.1%, median age: 61.0 years, IQR 50.0-71.2, 48% men). The frequency of infectious skin diseases (39.3% vs. 21.6% P = 0.002) were higher in RTR than in patients with CKD. Neoplastic skin lesions were present in nine (4.4%) RTR and in only one (1.0%) patient with CKD. Among the RTR, the ratio of basal cell carcinoma to squamous cell carcinoma was 2:1. CONCLUSIONS: This study revealed that an increased frequency of infectious skin diseases may be expected in patients who have undergone kidney transplantation. Among skin cancers, BCC is more frequently observed in RTR, especially in those using azathioprine.
RESUMEN
ABSTRACT Objective: To understand the perceptions of mobile health technology use in adherence to the treatment of patients with chronic kidney disease under hemodialysis. Method: This is a descriptive study, with a qualitative approach, carried out in a reference hemodialysis clinic in the city of Juazeiro, Bahia, Brazil. Patients with chronic kidney disease under hemodialysis who used the Renal Health application between February and October 2022 were included in the study. The data was analyzed using the content analysis method. Results: A total of 12 patients were interviewed, the majority of whom were male, with an average age of 35.3 (±9.7) years and an average of 2.7 (±1.5) years of hemodialysis. After analyzing the content, two thematic categories emerged: "Support from mHealth technology in treatment management" and "Suggestions for improving the application", in which patients describe how the application is practical, favors the storage of information related to treatment, such as weight, water intake and medication taking times. In addition to generating graphs of the exams carried out monthly, it provides strategies that can promote disease self-management and consequently better adherence to treatment. Conclusion: The Renal Health application proved to be a useful tool capable of enhancing knowledge about chronic kidney disease and helping patients better manage their diet, fluid control and taking prescribed medications.
RESUMEN Objetivo: comprender las percepciones sobre el uso de la tecnología móvil de salud en la adherencia al tratamiento de pacientes con enfermedad renal crónica en hemodiálisis. Método: estudio descriptivo, con enfoque cualitativo, realizado en una clínica de referencia en hemodiálisis de la ciudad de Juazeiro, Bahia, Brazil. Se incluyeron en el estudio pacientes en hemodiálisis renal crónica que utilizaron la aplicación Renal Health entre los meses de febrero y octubre de 2022. Los datos se analizaron mediante el método de análisis de contenido. Resultados: se entrevistaron 12 pacientes, la mayoría del sexo masculino, con una edad promedio de 35,3 (±9,7) años y un promedio de 2,7 (±1,5) años de hemodiálisis. Tras el análisis del contenido surgieron dos categorías temáticas: "Apoyo de la tecnología mHealth en la gestión del tratamiento" y "Sugerencias para mejorar la aplicación", en el que los pacientes describen cómo la aplicación es práctica, favorece el almacenamiento de información relacionada con el tratamiento, como peso, ingesta de agua y tiempos de toma de medicamentos. Además de generar gráficos de los exámenes realizados mensualmente, brinda estrategias que pueden promover el autocontrol de la enfermedad y en consecuencia una mejor adherencia al tratamiento. Conclusión: la aplicación Renal Health demostró ser una herramienta útil capaz de mejorar el conocimiento sobre la enfermedad renal crónica y ayudar a los pacientes a gestionar mejor su dieta, control de líquidos y toma de medicamentos prescritos.
RESUMO Objetivo: compreender as percepções do uso de uma tecnologia mobile health na adesão ao tratamento do paciente renal crônico em hemodiálise Método: estudo descritivo, com abordagem qualitativa, realizado em uma clínica de referência em hemodiálise no município de Juazeiro, Bahia, Brasil. Foram incluídos no estudo pacientes renais crônicos hemodialíticos que utilizaram o aplicativo Renal Health entre os meses de fevereiro a outubro de 2022. Os dados foram analisados através do método análise de conteúdo Resultados: foram entrevistados 12 pacientes, a maioria do sexo masculino, idade média de 35,3 (±9,7) anos e média de 2,7 (±1,5) anos de hemodiálise. Após análise do conteúdo surgiram duas categorias temáticas: "Apoio da tecnologia mHealth no gerenciamento do tratamento" e "Sugestões para aperfeiçoamento do aplicativo", nas quais os pacientes descrevem como o aplicativo é prático, favorece o armazenamento de informações relacionadas ao tratamento, como peso, ingestão hídrica e horário da tomada de medicamentos. Além de gerar gráficos dos exames realizados mensalmente, proporcionando estratégias que podem favorecer o autogerenciamento da doença e consequentemente uma melhor adesão ao tratamento. Conclusão: o aplicativo Renal Health, demonstrou ser uma ferramenta útil, capaz de potencializar o conhecimento sobre a doença renal crônica e auxiliar os pacientes a gerenciarem melhor a dieta, o controle de líquidos e a tomada das medicações prescritas.
RESUMEN
Resumo A avaliação da função renal é feita por meio da taxa de filtração glomerular (TFG), que pode ser determinada pelo clearance de creatinina (CrCl) e é dependente da coleta urinária de 24 horas (h), o que dificulta o seu uso na atenção primária. As equações que estimam a TFG a partir da creatinina sérica tornam o exame mais acessível, contudo, os seus ajustes por raça/cor têm sido questionados em populações miscigenadas. Para verificar a concordância entre o ClCr e a TFG estimada por fórmulas (Modification of Diet in Renal Disease [MDRD-4] e Chronic Kidney Disease Epidemiology Collaboration [CKD-EPI]), com ou sem ajuste por raça/cor, foram utilizados dados de subestudo da Pesquisa Nacional de Saúde (PNS) com inclusão de 272 adultos de Vitória, Espírito Santo, que fizeram coleta urinária de 24h. Adotou-se análise de variância (ANOVA) e método de Bland-Altman. Houve concordância adequada entre o ClCr e as equações, mas o ajuste por raça/cor diminui a acurácia destas últimas. No fator raça/cor, houve semelhança entre grupos para o ClCr (p=0,21) sugerindo não haver diferença no metabolismo da creatinina em função da cor da pele. Conclui-se que MDRD-4 e CKD-EPI apresentam desempenho satisfatório na avaliação da função renal, não sendo recomendado o uso de correções para raça/cor.
Abstract The assessment of renal function is performed using the glomerular filtration rate (GFR) whose measurement by creatinine clearance (ClCr) and is dependent on a 24-hour urine sample, hindering it use in primary healthcare. The equations that estimate GFR from serum creatinine make the test more accessible, however, their adjustments by race/color have been questioned in mixed populations. To test the agreement between CrCl and GFR estimated by formulas (Modification of Diet in Renal Disease [MDRD-4] and Chronic Kidney Disease Epidemiology Collaboration [CKD-EPI]), with or without adjusting for race/color, data were used from a sub-study of the National Health Survey (NHS) including 272 adults from Vitória/Espírito Santo who underwent a 24-hour urinary sampling. Analysis of variance (ANOVA) and the Bland-Altman method were adopted. There was adequate agreement between ClCr and equations, but the adjustment by race/color decreases the accuracy of both equations. In the race/color factor, there was similarity between groups for CrCl (p=0.21), suggesting that there is no difference in creatinine metabolism induced by skin color. It is concluded that MDRD and CKD-EPI equations perform satisfactorily in the evaluation of renal function, and the use of corrections for race/color is not recommended.
RESUMEN
Introducción: el síndrome cardiorrenal es una patología dada por la disfunción en la interdependencia de estos órganos por interacciones bidireccionales (agudas o crónicas), los cuales pueden afectar indistintamente la función renal o ventricular. Objetivo: presentar y justificar la enfermedad renal crónica como desencadenante de cuadros congestivos por falla cardiaca de novo. Presentación del caso: se reporta el caso de un paciente masculino de 69 años revascularizado percutáneamente hace tres años con múltiples comorbilidades que ingresa en el contexto de una falla cardiaca de novo, secundaria a su enfermedad renal crónica estadio V de base, en manejo con hemodiálisis y en quien se descartó enfermedad coronaria aguda y miocardiopatía infiltrativa. Se logró estabilizar la injuria renal y cardiaca dando egreso y continuando manejo ambulatorio de sus patologías, al llevar un control adecuado de las mismas con Nefrología y Cardiología. Discusión y conclusión: la enfermedad cardiovascular generada por antecedentes renales tiene una gran repercusión en la función ventricular izquierda, causando hipertrofia, lo que lleva a una congestión con posterior sobrecarga debido a la caída del filtrado glomerular y que resulta en la disminución de la fracción de eyección. La enfermedad renal crónica predispone a alteraciones en la función cardiaca, lo que aumenta el riesgo cardiovascular.
Background: Cardiorenal syndrome is a pathology caused by dysfunction in the interdependence of these organs due to bidirectional interactions (acute or chronic), which can affect either renal or ventricular function. Purpose: To present and justify chronic kidney disease as a trigger of congestive conditions due to de novo heart failure. Case presentation: We report the case of a 69-year-old male patient percutaneously revascularized 3 years ago with multiple comorbidities who was admitted in the context of de novo heart failure secondary to his stage V chronic kidney disease on hemodialysis, in whom acute coronary artery disease and infiltrative cardiomyopathy were ruled out. The renal and cardiac injury was stabilized and the patient was discharged and continued outpatient management of his pathologies with adequate control of the same with nephrology and cardiology. Discussion and conclusion: Cardiovascular disease generated by renal history has great repercussion in left ventricular function causing hypertrophy that leads to congestion with subsequent overload due to the fall of glomerular filtration resulting in a decrease of the ejection fraction. Chronic kidney disease predisposes to alterations in cardiac function increasing cardiovascular risk.
RESUMEN
Acute Kidney Injury (AKI) is a frequent complication in intensive care unit (ICU) patients that increases mortality and chronic kidney disease (CKD) development. AKI is associated with elevated plasma fibroblast growth factor 23 (FGF23), which can be modulated by erythropoietin (EPO) and Klotho. We aimed to evaluate whether a combined biomarker that includes these molecules predicted short-/long-term outcomes. We performed a prospective cohort of ICU patients with sepsis and previously normal renal function. They were followed during their inpatient stay and for one year after admission. We measured plasma FGF23, EPO, and Klotho levels at admission and calculated a combined biomarker (FEK). A total of 164 patients were recruited. Of these, 50 (30.5%) had AKI at admission, and 55 (33.5%) developed AKI within 48 h. Patients with AKI at admission and those who developed AKI within 48 h had 12- and 5-fold higher FEK values than non-AKI patients, respectively. Additionally, patients with higher FEK values had increased 1-year mortality (41.9% vs. 18.6%, p = 0.003) and CKD progression (26.2% vs. 8.3%, p = 0.023). Our data suggest that the FEK indicator predicts the risk of AKI, short-/long-term mortality, and CKD progression in ICU patients with sepsis. This new indicator can improve clinical outcome prediction and guide early therapeutic strategies.
Asunto(s)
Lesión Renal Aguda , Eritropoyetina , Insuficiencia Renal Crónica , Sepsis , Humanos , Estudios Prospectivos , Factor-23 de Crecimiento de Fibroblastos , Cuidados Críticos , Sepsis/complicaciones , BiomarcadoresRESUMEN
Introducción. El trasplante es la mejor opción de tratamiento para los pacientes con enfermedad renal terminal, sin embargo, existe discrepancia entre las listas de espera y la disponibilidad de órganos a partir de la donación cadavérica. Buscando aumentar el número de órganos disponibles se implementó el trasplante con donante vivo. A partir de la introducción de técnicas mínimamente invasivas para la nefrectomía, el donante vivo ha logrado cifras cercanas al 50 % de los trasplantes realizados en muchas instituciones, debido a los beneficios propios del procedimiento. El objetivo de este estudio fue describir los resultados después de la incorporación del procedimiento totalmente laparoscópico en nuestra institución. Métodos. Se hizo un análisis retrospectivo de las características de los pacientes llevados a nefrectomía para obtención de injerto por técnica totalmente laparoscópica y los resultados en un solo centro en Cali, Colombia, desde noviembre de 2019 hasta octubre de 2022. Los datos fueron obtenidos mediante la revisión de las historias clínicas electrónicas. Resultados. Se realizaron 78 nefrectomías para obtención de injerto con técnica totalmente laparoscópica. El tiempo operatorio promedio fue de 152 minutos, el sangrado promedio fue de 12 ml, la estancia hospitalaria promedio del donante fue de 2,8 días. La tasa de complicaciones fue de 7,6 % (4 pacientes con complicación Clavien-Dindo I y 2 pacientes Clavien-Dindo IIIb). No se presentó ningún caso de mortalidad. Conclusiones. La técnica totalmente laparoscópica resulta ser una técnica segura con baja tasa de morbilidad y excelentes beneficios para los donantes.
Introduction. Kidney transplant is the best treatment option for end-stage renal disease. However, the discrepancy between waiting lists and the availability of organs from cadaveric donation is well known. Organ transplantation with a living donor was implemented to increase the number of organs available. Since the introduction of minimally invasive techniques for nephrectomy, living donors have achieved figures close to 50% of transplants performed in many institutions due to the procedure's benefits. In our country, the experiences described are from the hand-assisted technique. This is the first description after incorporating the laparoscopic procedure. Methods. A retrospective analysis of the characteristics and results of all patients undergoing nephrectomy to obtain a graft using a laparoscopic technique was carried at a single center in Cali, Colombia, from November 2019 to October 2022. The electronic medical records were reviewed to obtain the data. Results. Seventy-eight nephrectomies were performed to obtain a graft with a laparoscopic technique. The mean operating time was 152 minutes, the average bleeding was 12 cc, and the average hospital stay was 2.8 days. The complication rate was 7.6% (four patients with Clavien-Dindo I complication and two Clavien-Dindo IIIb patients). There were no cases of mortality. Conclusions. The laparoscopic technique is safe, with a low morbidity rate and excellent benefits.
Asunto(s)
Humanos , Trasplante de Riñón , Laparoscopía , Nefrectomía , Trasplante , Obtención de Tejidos y Órganos , Insuficiencia Renal CrónicaRESUMEN
The word sarcopenia derives from the Greek terms "sarx" for meat and "penia" for loss, thus being used to define reductions in muscle mass, muscle strength, and lower physical performance that compromise, mainly, the elderly population. Its high negative impact on patients' quality of life encourages the production and publication of new studies that seek to find methods to prevent and reverse cases of loss of muscle mass and strength. Furthermore, the high prevalence of sarcopenia in patients with chronic kidney disease (CKD) is closely related to its pathophysiology, which consists of a state of increased protein catabolism and decreased muscle tissue synthesis. Also considering the inflammatory nature of CKD and sarcopenia, the purinergic system has been an important target of studies, which seek to relate it to the two previous conditions. This system achieves anti-inflammatory action by inhibiting, through adenosine, pro-inflammatory factors such as interleukin-12 (IL-12), tumor necrosis factor alpha (TNF-α), and nitric oxide (NO), as well as by releasing anti-inflammatory substances such as interleukin-10 (IL-10). Simultaneously, the purinergic system presents pro-inflammatory activity, signaled by adenosine triphosphate (ATP), which occurs through the activation of T cells and the release of pro-inflammatory factors such as those mentioned above. Therefore, the ability of this system to act on inflammatory processes can promote positive and negative changes in the clinical aspect of patients with CKD and/or sarcopenia. Furthermore, it appears that there is a correlation between the practice of repeated physical exercise with the clinical improvement and in the quality of life of these patients, presenting a decrease in the levels of C-reactive protein (CRP), NTPDase, and the pro-inflammatory cytokine IL-6, such as increases in IL-10 resulting from modulation of the purinergic system. In this way, the present article seeks to evaluate the effect of physical exercise as a modulator of the purinergic system in the control of sarcopenia in patients with CKD on hemodialysis, in order to trace a relationship that can bring benefits both for biological markers and for quality of life of these patients.
RESUMEN
Contexto: dada la importancia de incorporar la calidad de vida durante la atención de los pacientes con enfermedad renal crónica (ERC), es necesario disponer de versiones traducidas y adaptadas transculturalmente de diferentes instrumentos diseñados para la medición de este constructo. Objetivo: traducir y adaptar transculturalmente al español hablado en Colombia el instrumento Kidney Disease Questionnaire (KDQ), para medir la calidad de vida en pacientes con ERC en insuficiencia renal. Metodología: el proceso se llevó a cabo siguiendo la metodología propuesta por la Eortc, que incluye traducciones directas, traducciones inversas y una prueba piloto llevada a cabo en un grupo de pacientes con diagnóstico de ERC en diálisis, atendidos en unidades renales de Baxter Renal Care Services®, en Bogotá, Colombia. Resultados: en el proceso se identificaron (I) casos que requirieron de consenso para seleccionar la traducción que mejor conservaba el significado y la equivalencia semántica del instrumento, (II) diferencias en la sintaxis o uso de paráfrasis, (III) se consideró pertinente realizar algunos cambios mínimos en el uso o la disposición de preposiciones o artículos, con el fin de que los ítems y las opciones de respuesta se leyeran de una manera más natural. Los cambios más notorios fueron en los ítems 18, 19 y 21, en los que para una mejor compresión de la pregunta, se identificó la necesidad de agregar determinadas expresiones o palabras. Conclusiones: se tiene disponible la versión traducida al español y adaptada culturalmente a la población colombiana del KDQ. El siguiente paso a fin de utilizar el instrumento en el país, es disponer de evidencia sobre sus propiedades clinimétricas.
Background: Considering the importance of incorporating quality of life during the care of patients with chronic kidney disease (CKD), it is necessary to have translated and cross-culturally adapted versions of different instruments designed to measure this construct. Purpose: To translate and cross-culturally adapt the Kidney Disease Questionnaire (KDQ) instrument for measuring quality of life in patients with CKD in renal failure to the Spanish spoken in Colombia. Methodology: The process was carried out following the methodology proposed by the EORTC, which includes direct translations, reverse translations and pilot test carried out in a group of patients with a diagnosis of CKD on dialysis, attended in renal units of Baxter Renal Care Services ®, in Bogota, Colombia. Results: In the process, cases were identified that required consensus to select the translation that best preserved the meaning and semantic equivalence of the instrument; differences in syntax or use of paraphrases; it was considered pertinent to make some minimal changes in the use or arrangement of prepositions or articles, so that the items and answer options would read in a more natural way; the most notorious changes were in items 18, 19 and 21, in which for a better understanding of the question, the need to add certain expressions or words was identified. Conclusions: The Spanish translated version and culturally adapted to the Colombian population of the KDQ is now available. The next step in order to use the instrument in the country is to have evidence on its clinimetric properties.
RESUMEN
Cinnamon, a member of the Lauraceae family, has been widely used as a spice and traditional herbal medicine for centuries and has shown beneficial effects in cardiovascular disease, obesity, and diabetes. However, its effectiveness as a therapeutic intervention for chronic kidney disease (CKD) remains unproven. The bioactive compounds within cinnamon, such as cinnamaldehyde, cinnamic acid, and cinnamate, can mitigate oxidative stress, inflammation, hyperglycemia, gut dysbiosis, and dyslipidemia, which are common complications in patients with CKD. In this narrative review, we assess the mechanisms by which cinnamon may alleviate complications observed in CKD and the possible role of this spice as an additional nutritional strategy for this patient group.
RESUMEN
Abstract Background Atrial fibrillation (AF) is the most common arrhythmia in patients with end-stage renal disease (ESRD). The coexistence of high thromboembolic and hemorrhagic risks, added to the lack of strong scientific evidence on the safety of anticoagulants in the setting of renal failure, makes this a clinically challenging situation. Objectives To describe the clinical-demographic profile and prevalence of AF in the population with ESRD undergoing dialysis. Secondary objectives include the assessment of thromboembolic (CHA2DS2VASC) and bleeding (HASBLED) risk scores. Methods Cross-sectional analytical-descriptive study, carried out between January and March 2020. Patients with ESRD were evaluated by means of a medical history questionnaire, physical examination, and 12-lead electrocardiogram. A chi-square (χ2) association test was applied to calculate association between clinical variables and AF, with a significance level of α = 0.05. Results This study evaluated 295 patients, most of whom were men (170), elderly (63, IQR 53-71), current smokers (130), with associated cardio-endocrine comorbidities. The prevalence of AF was 6.7% (20). Heart failure (HF) (χ2=15.417; p<0.001), age of 65 years or older (χ2=14.584; p<0.001), and anticoagulation (χ2=5.715; p<0.01) were associated with AF. The median CHA2DS2VASC and HASBLED was 4 and 3, respectively. Eight patients were taking warfarin and five were receiving apixaban. Conclusion The prevalence of AF in this study is similar to that reported in other published articles on the subject, and patients were at high risk for cardiovascular outcomes. Non-anticoagulation strategy was commonly adopted due to controversies in the literature as well as the absence of published randomized clinical trials.
RESUMEN
The significant growth in the number of individuals dependent on hemodialysis for renal replacement therapy and unrestricted use of short and long-term catheters have challenged vascular surgeons in search of solutions for patients whose options for access via the upper limbs have been exhausted and for the increasing rates of central venous stenosis in these patients. When access via the upper limbs is impossible, exceptional techniques can be used and the lower limbs offer feasible alternative vascular access sites for hemodialysis. This article reports a case of superficial femoral vein transposition to make a loop arteriovenous fistula in a patient with no possibility of access via the upper limbs and presents a literature review on this technique that remains little used.
RESUMEN
We performed a descriptive study to characterize effects from COVID-19 among chronic dialysis patients compared with the general population in Argentina during March 2020-February 2021. COVID-19 case-fatality rate of chronic dialysis patients was 10 times the national rate; the age-standardized mortality ratio was 6.8 (95% CI 6.3-7.3).
Asunto(s)
COVID-19 , Pandemias , Humanos , COVID-19/epidemiología , SARS-CoV-2 , Argentina/epidemiología , Diálisis RenalRESUMEN
Introduction: Chronic kidney disease (CKD) and the number of transgender people is on the rise. Hormone replacement therapy may be associated with the development of adverse effects, including kidney disease. Objective: To report the case of a transgender patient using hormone therapy who developed CKD. Case Report: Male transgender patient, 28 years old, using testosterone cypionate every 15 days, without any comorbidity. Evolved with hypertensive peaks of 160-150/110 mmHg and loss of kidney function (Ur 102 mg/dl, Cr 3.5 mg/dl, estimated Glomerular Filtration Rate (eGFR) of 22 ml/min/1.73m2 considering male gender and 16.6 ml/min/1.73m2 considering female gender). Abdominal ultrasound showed chronic parenchymal nephropathy. Due to the significant reduction in eGFR, the patient was referred for kidney transplantation, but he was not included in the list because he had a creatinine clearance of 23 ml/min/1.73m2 for males and 21.5 ml/min/1.73m2 for females in the most recent tests. Conclusion: Hormone replacement may have contributed to the increase in the patient's blood pressure and, consequently, to the development of CKD. There is still no well-established consensus on the best way to estimate the GFR in transgender people, and it seems to be more appropriate to consider the gender to which the person self-identifies or to perform the calculation for both genders, obtaining an estimate of the range in which the patient's GFR lies.
Asunto(s)
Insuficiencia Renal Crónica , Personas Transgénero , Adulto , Creatinina , Cistatina C , Femenino , Tasa de Filtración Glomerular , Hormonas , Humanos , MasculinoRESUMEN
RESUMEN Introducción: las infecciones relacionadas a catéteres utilizados en hemodiálisis constituyen una de las causas de morbimortalidad más frecuentes. No se dispone de estudios previos en el Paraguay que demuestren la diferencia entre tratamiento empírico y dirigido de infección relacionada a catéter de hemodiálisis Objetivo: determinar la evolución clínica del tratamiento empírico de la infección relacionada a catéter versus el tratamiento dirigido en pacientes adultos. Material y métodos: se aplicó un diseño observacional, retrospectivo, de corte transversal que incluyó 128 pacientes internados en el Hospital Nacional, Itauguá, Paraguay, durante los años 2020 y 2021. Fueron divididos en grupos de tratamiento dirigido (64 pacientes) y empírico (64 pacientes). Resultados: la edad media fue 52 ± 14 años. El acceso vascular yugular fue el más utilizado (78,91%). Se observó que el transcurso de días entre la colocación de catéter de hemodiálisis hasta su infección fue 16 ± 7,6 días. El crecimiento microbiano predominante en ambos grupos fue de cocos gram positivos (84,37%). S. aureus se aisló en 84,31% del grupo tratamiento dirigido y en 15,68% del grupo con tratamiento empírico. El grupo antibiótico más utilizado en ambos grupos fueron los glucopéptidos (77,34%) y la combinación más utilizada fue ciprofloxacina con vancomicina tanto en el grupo dirigido (37,5%) como en el empírico (31,25%). El desenlace curación de infección se observó en 90,62% en el grupo de tratamiento empírico y en 82,81% en el grupo dirigido. La frecuencia de sepsis fue 17,18% en el grupo empírico y 32,8% en grupo dirigido. La mortalidad fue 9,37% en grupo empírico y 14,06% en grupo dirigido. Conclusión: el germen más prevalente fue S. aureus. La curación de infección relacionada a catéter fue más frecuente en el grupo empírico, la mortalidad y sepsis predominaron en el grupo dirigido.
ABSTRACT Introduction: Infections related to catheters used in hemodialysis are one of the most frequent causes of morbidity and mortality. There are no previous studies in Paraguay that demonstrate the difference between empirical and directed treatment of hemodialysis catheter-related infection. Objective: To determine the clinical course of empirical treatment versus targeted treatment of catheter-related infection in adult patients. Material and methods: An observational, retrospective, cross-sectional design was applied including 128 patients admitted to the Hospítal Nacional of Itauguá, Paraguay, during the years 2020 and 2021. They were divided into directed (64 patients) and empirical (64 patients) treatment groups. Results: The mean age was 52 ± 14 years. The jugular vascular access was the most used (78.91%). It was observed that the time between hemodialysis catheter placement and infection was 16±7.6 days. The predominant microbial growth in both groups was gram-positive cocci (84.37%). S. aureus was isolated in 84.31% of the directed treatment group and in 15.68% of the empirical treatment group. The most used antibiotic group in both groups were glycopeptides (77.34%) and the most used combination was ciprofloxacin with vancomycin, both in the targeted group (37.5%) and in the empirical group (31.25%). The outcome of infection cure was observed in 90.62% in the empirical treatment group and in 82.81% in the directed group. The frequency of sepsis was 17.18% in the empirical group and 32.8% in the directed group. Mortality was 9.37% in the empirical group and 14.06% in the directed group. Conclusion: The most prevalent germ was S. aureus. Cure of catheter-related infection was more frequent in the empiric group, while mortality and sepsis predominated in the directed group.
RESUMEN
RESUMEN Introducción: la endocarditis infecciosa es una enfermedad de una variada presentación clínica. Es cada vez más frecuente debido a los cuidados relacionados con la salud. Objetivo: determinar las complicaciones de los pacientes con endocarditis infecciosa bacteriana al momento del diagnóstico y su relación con el agente causal y ofrecer una descripción general de las características demográficas y clínicas presentes en pacientes del Hospital Nacional, Itauguá, Paraguay, en el periodo 2017-2021. Material y métodos: estudio descriptivo, observacional, retrospectivo que incluyo 37 pacientes con el diagnóstico de endocarditis infecciosa con germen aislado. Resultados: la edad media fue 45 ±14 años, la mayoría provenía del área urbana y era del sexo masculino (65%). La comorbilidad más frecuente fue enfermedad renal crónica (50%). Los procedimientos invasivos (catéter venoso central simple) fueron el foco de bacteriemia más frecuente (65,22%). La válvula más comprometida fue la aórtica, la complicación más frecuente fue la insuficiencia cardiaca (70,27%), hubieron 49% de desenlaces fatales. El germen más frecuente y causante de la mayor morbimortalidad fue Staphylococcus aureus (43,24%). Conclusión: la enfermedad renal crónica fue el principal factor de riesgo. Ser portador de catéter venoso simple de hemodiálisis estuvo relacionado al aislamiento del Staphylococcus aureus como agente causal más frecuente. Este germen estuvo relacionado a la alta tasa de complicaciones al momento del ingreso y con el alto porcentaje de desenlaces fatales.
ABSTRACT Introduction: Infective endocarditis is a disease with a varied clinical presentation. It is becoming more frequent due to health-related care. Objective: To determine the complications of patients with bacterial infective endocarditis at the time of diagnosis and their relationship with the causal agent and offer a general description of the demographic and clinical characteristics present in patients of the Hospital Nacional of Itauguá, Paraguay, in the period 2017- 2021. Material and methods: Descriptive, observational, retrospective study that included 37 patients diagnosed with infective endocarditis with isolated germ. Results: The mean age was 45±14 years, the majority came from the urban area and was male (65%). The most frequent comorbidity was chronic kidney disease (50%). Invasive procedures (simple central venous catheter) were the most frequent source of bacteremia (65.22%). The most compromised valve was the aortic, the most frequent complication was heart failure (70.27%) and there was 49% of fatal outcomes. The most frequent germ and cause of the highest morbidity and mortality was Staphylococcus aureus (43.24%). Conclusion: Chronic kidney disease was the main risk factor. Being a carrier of a simple venous hemodialysis catheter was related to the isolation of Staphylococcus aureus as the most frequent causal agent. This germ was related to the high rate of complications at the time of admission and the high percentage of fatal outcomes.
RESUMEN
Perforating dermatoses are papulonodular cutaneous pathologies characterized by transepithelial extrusion of components of the extracellular matrix of the dermis, by inflammation or degeneration. When secondary, the systemic diseases are called Acquired Perforating Diseases. Our letter aims to report a case of acquired perforating dermatoses secondary to chronic renal dialysis. The treatment with Allopurinol proved to be effective in this case. Allopurinol would act as an antioxidant, reducing the inflammatory reaction in tissues and consequent damage to the collagen fibers (AU)
Dermatoses perfurantes são patologias cutâneas papulonodulares que se caracterizam pela extrusão transepitelial de componentes da matriz extracelular da derme, por inflamação ou degeneração. Quando são secundárias as doenças sistêmicas são chamadas Doenças Perfurantes Adquiridas. Nossa carta tem como objetivo relatar caso de dermatose perfurante adquirida secundária a insuficiência renal crônica dialítica. O tratamento com Alopurinol se mostrou eficaz neste caso. O Alopurinol atuaria como antioxidante, reduzindo a reação inflamatória nos tecidos e consequentes danos nas fibras colágenas (AU)
Asunto(s)
Humanos , Prurigo , Enfermedades de la Piel/terapia , Alopurinol/uso terapéutico , Vía Perforante , Insuficiencia Renal CrónicaRESUMEN
Resumo Introdução A hemodiálise costuma se estender até o final da vida ou até o transplante renal. Objetivo verificar os fatores relacionados aos desfechos clínicos e à sobrevida de doentes renais crônicos em tratamento hemodialítico em uma clínica do sul de Santa Catarina. Método Estudo de coorte retrospectivo. A sobrevida foi avaliada por curvas de Kaplan-Meier e os fatores relacionados ao desfecho, por meio de regressão de Cox, expressos por meio do Hazard Ratio (HR) e intervalo de confiança de 95%. Resultados Entre 120 pacientes, a média de idade foi de 61,8 (±13,9) anos. O principal encaminhamento para hemodiálise foi do nefrologista (33,3%). As principais doenças de base identificadas foram hipertensão arterial (60,8%) e Diabetes Mellitus (29,2%). Foi registrado óbito em 44,2% dos pacientes e sete (5,8%) realizaram transplante. A sobrevida diminuiu de 76,1% em um mês para 49,3% em um ano de tratamento. Encaminhamentos pela UTI (HR 18,1 IC95% 4,49-72,8) e pela Unidade Básica de Saúde (HR 9,27 IC95% 1,48-58,2) foram associados ao óbito, além de valores maiores de cálcio inicial (HR 2,36 IC95% 1,21-4,62) e menores de creatinina final (HR 0,69 IC95% 0,55-0,87). Conclusão O principal desfecho verificado foi o óbito, sendo a sobrevida dos pacientes, avaliada em curto prazo, abaixo do esperado, sugerindo encaminhamento tardio ao tratamento substitutivo.
Abstract Background Hemodialysis usually lasts until the end of life or until kidney transplantation. Objective to verify the factors related to clinical outcomes and survival of chronic renal patients in hemodialysis at a clinic in the south of Santa Catarina Method A retrospective cohort study. Survival was assessed by Kaplan-Meier curves and outcome-related factors were assessed using Cox regression, with comparisons using Hazard Ratio (HR) and 95% confidence intervals. Results Among the 120 patients, the mean age was 61.8 (± 13.9) years. The main sector of referral for hemodialysis was the nephrologist (33.3%). The main underlying diseases identified were hypertension (60.8%) and Diabetes Mellitus (29.2%). Death was recorded in 44.2% of the patients, and seven (5.8%) performed a transplant. Survival decreased from 76.1% in one month to 49.3% in one year of treatment. Referral by intensive care unit (HR 18.1 95% CI 4.49-72.8) and Basic Health Unit (HR 9.27 95% CI 1.48-58.2) were associated with death, besides of higher values of initial calcium (HR 2.36 95%CI 1.21-4.62) and lower final creatinine (HR 0.69 95%CI 0.55-0.87). Conclusion The main outcome was death, being the patient´s survival, evaluated in a short term, lower than expected, suggesting late referral to the substitutive treatment.